A subcutaneously administered anticoagulant for the treatment and secondary prevention of thromboembolism in patients with acute, symptomatic, deep vein thrombosis or pulmonary embolism.
Horizon Scanning
It is a challenge for health plans and clinicians to know what emerging technologies are in the preapproval phase and what their clinical, financial, and risk impacts might be. This is where we come in.The Hayes Horizon Scanning Solution identifies innovative and potentially disruptive health technologies that are in various stages of the regulatory approval process. Our Research Analysts continually investigate new technologies that are on the horizon or in the early stages of clinical investigation, as well as the testing of existing technologies that may be seeking approval for new clinical applications. Hayes Horizon Scanning helps you track emerging technologies before you need to make decisions. Accessed through the Hayes Knowledge Center, Hayes Horizon Scanning addresses the following fundamental questions to help our clients forecast emerging technologies:
- Is this emerging technology new or replacing an existing technology?
- Where is this technology in the FDA regulatory process?
- When will this technology be commercially available in the market?
- What is the projected use, cost, and financial impact of this technology?
Omigard™ (MBI-226, Omiganan Pentahydrochloride 1% Gel)
A topical antimicrobial agent to prevent catheter-related bloodstream infections by reducing the incidence of catheter colonization.
Arzoxifene
An oral selective estrogen receptor modulator for prevention and treatment of osteoporosis in postmenopausal women.
Multaq® (Dronedarone)
An oral, multichannel blocking, antiarrhythmic drug being developed for the management of atrial fibrillation or atrial flutter.
Saxagliptin (Onglyza™)
An oral agent for glycemic control in patients with type 2 diabetes mellitus.
Avastin® (Bevacizumab) for Metastatic Renal Cell Carcinoma
An intravenous monoclonal antibody for the first-line treatment of metastatic renal cell carcinoma.
Dirucotide
An intravenous drug for the treatment of secondary-progressive multiple sclerosis.
Cathamaran™ Intravascular Magnetic Resonance Imaging (IVMRI) System
An intravascular magnetic resonance imaging system consisting of a portable control unit and self-contained, single-use, 6F-compatible catheter probe containing a miniature magnet, intended for imaging vulnerable plaque in the coronary arteries.
Sugammadex (possibly Bridion®)
An intravenous drug for rapid reversal of nondepolarizing neuromuscular blockade in general anesthesia.
Vascular Wrap™ (Paclitaxel-Eluting Mesh Surgical Implant)
A bioabsorbable, paclitaxel-eluting surgical mesh implanted in conjunction with a synthetic vascular graft, around the distal anastomosis, to reduce stenosis rates in femoropopliteal peripheral bypass.